Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Adjuvant chemotherapy in gastric cancer.

Literature DB >> 3630192

Adjuvant chemotherapy in gastric cancer.

P Schlag.

Abstract

Entities: Disease

Mesh：

Substances：
Fluorouracil
Carmustine

Year: 1987 PMID： 3630192 DOI： 10.1007/BF01655812

Source DB: PubMed Journal: World J Surg ISSN： 0364-2313 Impact factor: 3.352

× No keyword cloud information.

32 in total

1. Concepts for systemic treatment of micrometastases.

Authors: F M Schabel
Journal: Cancer Date: 1975-01 Impact factor: 6.860

Review 2. Chemotherapy and combined modality therapy for locally advanced and metastatic gastric carcinoma.

Authors: T Le Chevalier; F P Smith; W K Harter; P S Schein
Journal: Semin Oncol Date: 1985-03 Impact factor: 4.929

3. Adjuvant 5-fluorouracil and BCNU chemotherapy in gastric cancer: 3-year results.

Authors: P Schlag; W Schreml; W Gaus; C Herfarth; M M Linder; W Queisser; M Trede
Journal: Recent Results Cancer Res Date: 1982

4. Postoperative adjuvant chemotherapy for gastric carcinoma. Analysis of data on 1805 patients followed for 5 years.

Authors: K Inokuchi; T Hattori; T Taguchi; O Abe; N Ogawa
Journal: Cancer Date: 1984-06-01 Impact factor: 6.860

5. 5-Fluorouracil, 1,3-bis(2-chloroethyl)-1-nitrosourea, and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea: effect on the human granulopoietic system.

Authors: H P Lohrmann; K A Lepp; W Schreml
Journal: J Natl Cancer Inst Date: 1982-04 Impact factor: 13.506

6. Ten year follow-up results of patients with carcinoma of the breast in a co-operative clinical trial evaluating surgical adjuvant chemotherapy.

Authors: B Fisher; N Slack; D Katrych; N Wolmark
Journal: Surg Gynecol Obstet Date: 1975-04

7. The current status of chemotherapy for gastric cancer in Japan with special emphasis on mitomycin C.

Authors: Y Koyama
Journal: Recent Results Cancer Res Date: 1978

8. Postoperative adjuvant 5-fluorouracil plus methyl-CCNU therapy for gastric cancer patients. Eastern Cooperative Oncology Group study (EST 3275).

Authors: P F Engstrom; P T Lavin; H O Douglass; K W Brunner
Journal: Cancer Date: 1985-05-01 Impact factor: 6.860

9. Leukemia and preleukemia after adjuvant treatment of gastrointestinal cancer with semustine (methyl-CCNU).

Authors: J D Boice; M H Greene; J Y Killen; S S Ellenberg; R J Keehn; E McFadden; T T Chen; J F Fraumeni
Journal: N Engl J Med Date: 1983-11-03 Impact factor: 91.245

10. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors: R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal: Br J Cancer Date: 1977-01 Impact factor: 7.640

5 in total

Adjuvant chemotherapy in gastric cancer.

1. Concepts for systemic treatment of micrometastases.

Review 2. Chemotherapy and combined modality therapy for locally advanced and metastatic gastric carcinoma.

3. Adjuvant 5-fluorouracil and BCNU chemotherapy in gastric cancer: 3-year results.

4. Postoperative adjuvant chemotherapy for gastric carcinoma. Analysis of data on 1805 patients followed for 5 years.

5. 5-Fluorouracil, 1,3-bis(2-chloroethyl)-1-nitrosourea, and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea: effect on the human granulopoietic system.

6. Ten year follow-up results of patients with carcinoma of the breast in a co-operative clinical trial evaluating surgical adjuvant chemotherapy.

7. The current status of chemotherapy for gastric cancer in Japan with special emphasis on mitomycin C.

8. Postoperative adjuvant 5-fluorouracil plus methyl-CCNU therapy for gastric cancer patients. Eastern Cooperative Oncology Group study (EST 3275).

9. Leukemia and preleukemia after adjuvant treatment of gastrointestinal cancer with semustine (methyl-CCNU).

10. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

1. Prognostic factors in resectable gastric cancer: results of EORTC study no. 40813 on FAM adjuvant chemotherapy.

2. Intravenous chemotherapy for resected gastric cancer: meta-analysis of randomized controlled trials.

Review 3. Chemotherapy for patients with gastric cancer after complete resection: a network meta-analysis.

Review 4. Pharmacotherapy for oesophagogastric cancer.

Review 5. Adjuvant therapy in resectable gastric cancer.